BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19549983)

  • 1. Activation of T cells: releasing the brakes by proteolytic elimination of Cbl-b.
    Schmitz ML
    Sci Signal; 2009 Jun; 2(76):pe38. PubMed ID: 19549983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
    Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G
    Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
    Loeser S; Penninger JM
    Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.
    Jeon MS; Atfield A; Venuprasad K; Krawczyk C; Sarao R; Elly C; Yang C; Arya S; Bachmaier K; Su L; Bouchard D; Jones R; Gronski M; Ohashi P; Wada T; Bloom D; Fathman CG; Liu YC; Penninger JM
    Immunity; 2004 Aug; 21(2):167-77. PubMed ID: 15308098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cbl-b deficiency prevents functional but not phenotypic T cell anergy.
    Nguyen TTT; Wang ZE; Shen L; Schroeder A; Eckalbar W; Weiss A
    J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33974042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
    Gómez-Martín D; Ibarra-Sánchez M; Romo-Tena J; Cruz-Ruíz J; Esparza-López J; Galindo-Campos M; Díaz-Zamudio M; Alcocer-Varela J
    Arthritis Rheum; 2013 Apr; 65(4):1032-42. PubMed ID: 23280105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cbl-b regulates the CD28 dependence of T-cell activation.
    Chiang YJ; Kole HK; Brown K; Naramura M; Fukuhara S; Hu RJ; Jang IK; Gutkind JS; Shevach E; Gu H
    Nature; 2000 Jan; 403(6766):216-20. PubMed ID: 10646609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular regulation of T-cell anergy.
    Zheng Y; Zha Y; Gajewski TF
    EMBO Rep; 2008 Jan; 9(1):50-5. PubMed ID: 18174897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
    Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
    Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.
    Bachmaier K; Krawczyk C; Kozieradzki I; Kong YY; Sasaki T; Oliveira-dos-Santos A; Mariathasan S; Bouchard D; Wakeham A; Itie A; Le J; Ohashi PS; Sarosi I; Nishina H; Lipkowitz S; Penninger JM
    Nature; 2000 Jan; 403(6766):211-6. PubMed ID: 10646608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.
    Fang D; Liu YC
    Nat Immunol; 2001 Sep; 2(9):870-5. PubMed ID: 11526404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte signaling: Cbl sets the threshold for autoimmunity.
    Rudd CE; Schneider H
    Curr Biol; 2000 May; 10(9):R344-7. PubMed ID: 10801434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Egr-2 and Egr-3 are negative regulators of T cell activation.
    Safford M; Collins S; Lutz MA; Allen A; Huang CT; Kowalski J; Blackford A; Horton MR; Drake C; Schwartz RH; Powell JD
    Nat Immunol; 2005 May; 6(5):472-80. PubMed ID: 15834410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 activation does not down-regulate Cbl-b expression in aged rat T-lymphocytes.
    Xu Z; George C; Jolly CA
    Mech Ageing Dev; 2004 Sep; 125(9):595-602. PubMed ID: 15491677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.
    St Rose MC; Qui HZ; Bandyopadhyay S; Mihalyo MA; Hagymasi AT; Clark RB; Adler AJ
    J Immunol; 2009 Oct; 183(8):4975-83. PubMed ID: 19801520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination.
    Zhang J; Bárdos T; Li D; Gál I; Vermes C; Xu J; Mikecz K; Finnegan A; Lipkowitz S; Glant TT
    J Immunol; 2002 Sep; 169(5):2236-40. PubMed ID: 12193687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy.
    Hsiao HW; Liu WH; Wang CJ; Lo YH; Wu YH; Jiang ST; Lai MZ
    Immunity; 2009 Jul; 31(1):72-83. PubMed ID: 19592273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells.
    Zha Y; Gajewski TF
    Cell Immunol; 2007 Jun; 247(2):95-102. PubMed ID: 17897636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.
    Qiao G; Zhao Y; Li Z; Tang PQ; Langdon WY; Yang T; Zhang J
    J Immunol; 2013 Jul; 191(2):632-9. PubMed ID: 23749633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 Ubiquitin Ligase Cbl-b Regulates Thymic-Derived CD4+CD25+ Regulatory T Cell Development by Targeting Foxp3 for Ubiquitination.
    Zhao Y; Guo H; Qiao G; Zucker M; Langdon WY; Zhang J
    J Immunol; 2015 Feb; 194(4):1639-45. PubMed ID: 25560411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.